![Christopher Zosh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Zosh
Finanzdirektor/CFO bei
STATERA BIOPHARMA, INC.
Profil
Christopher Zosh currently works at Panacela Labs, Inc., as Director from 2017 and Statera Biopharma, Inc., as EVP-Finance, Chief Financial & Accounting Officer from 2022.
Mr. Zosh also formerly worked at Cleveland BioLabs, Inc., as CAO, Chief Executive & Financial Officer from 2019 to 2021.
Mr. Zosh received his undergraduate degree from State University of New York at Buffalo.
Aktive Positionen von Christopher Zosh
| Unternehmen | Position | Beginn |
|---|---|---|
| STATERA BIOPHARMA, INC. | Finanzdirektor/CFO | 27.05.2022 |
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against cancer | Direktor/Vorstandsmitglied | 01.07.2017 |
Ehemalige bekannte Positionen von Christopher Zosh
| Unternehmen | Position | Ende |
|---|---|---|
| STATERA BIOPHARMA, INC. | Vorstandsvorsitzender | 27.07.2021 |
Ausbildung von Christopher Zosh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to activate the immune system and address serious medical needs | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs against cancer | Health Technology |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Statera Biopharma, Inc.
 Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
